| Gene symbol | IL13RA2 | Synonyms | CD213A2, CT19, IL-13R, IL13BP | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq23 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | interleukin 13 receptor subunit alpha 2 | ||||
| GTO ID | GTC3182 |
| Trial ID | NCT05540873 |
| Disease | Recurrent Malignant Glioma |
| Altered gene | IL13RA2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | YYB-103 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Clinical Study of IL13Rα2 Targeted CAR-T in Patients With Malignant Glioma (MAGIC-I) |
| Year | 2022 |
| Country | Korea,Republic of |
| Company sponsor | CellabMED |
| Other ID(s) | CLM_103_MG001 |
| Cohort 1 | |||||||
|
|||||||